In total breast cancer tissue, a significant increase of ChTL and CL proteasome activities was revealed, although the level of 20S proteasome in the primary tumor did not differ from the level in the adjacent tissue; only luminal B HER2-negative subtype BCPs with lymphogenic metastasis were characterized by significantly increased 20S proteasome level in the tissue. Here, ERBB2 is linked to breast carcinoma.